Sequenom Shares Climb Sharply This Week | GenomeWeb
NEW YORK (GenomeWeb News) – Shares of Sequenom were trading up 8.3 percent at $7.73 in Friday afternoon trade, two days after the firm reported a 7 percent increase first quarter revenues.
The San Diego-based firm’s stock has risen 36.8 percent since closing at $5.65 last Friday, and has climbed 22.3 percent since the close of the market on Wednesday, when it reported its financial results.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.